Cataract surgery-induced dry eye may not be a direct consequence of surgery

Article

Dry eye following cataract surgery may not be a direct result of the surgery but rather the surgery triggers symptoms in eyes with pre-existing sub-optimal tear properties.

Dry eye following cataract surgery may not be a direct result of the surgery but rather the surgery triggers symptoms in eyes with pre-existing sub-optimal tear properties, according to Waheeda Illahi and colleagues from BMEC, City Hospital, Birmingham, UK.

A study was conducted to assess tear quantity, break-up time and central corneal thickness following cataract surgery. Tear quantity was measured using a phenol red thread, fluorescein break-up time (measured in seconds) was quantified by standard biomicroscopy and central corneal thickness was measured by ultrasonic pachymetry after topical anaesthesia. Measurements were taken from right eyes in bilateral cases and age and gender matched controls.

The results showed that mean phenol red thread was 16.9 mm in the study group and 16.5 mm in the controls. Mean break-up time was 4.9 seconds in the study group and 4.6 seconds in the controls. Mean central corneal thickness was 541.2 µm in the study group and 539.0 µm in the controls. Comparisons revealed no statistical differences between the two groups but there was a significant correlation between break-up time and phenol red thread in the study group (r=0.265, p=0.028).

Although dry eye symptoms are often reported after cataract surgery, this study suggests that surgery is not the direct cause but rather that the surgery triggers symptoms in eyes with pre-existing sub-optimal tear properties.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.